Xoloninvest Asset Manager Profile - aVenture Research
Xoloninvest, based in Seoul, South Korea, focuses on early-stage investments and mezzanine financing. The firm targets both listed and unlisted companies, demonstrating a versatile approach to investment opportunities. While specific investment sizes are not disclosed, their involvement in Series B rounds suggests a commitment to supporting companies in their growth stages.
One of Xoloninvest's notable portfolio companies is Rebus Biosystems, which has raised a total of $20 million. This investment in the biotechnology sector indicates Xoloninvest's interest in innovative and potentially disruptive technologies. The firm's strategy appears to blend financial services expertise with a focus on nurturing promising early-stage ventures across various industries.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.
